18242 Federal Register / Vol. 74, No. 75 / Tuesday, April 21, 2009 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel, Review of Collaborative 

Study on the Genetics of Alcoholism. 

Date: May 13–15, 2009. 

Time: May 13, 2009, 4 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel at the Chevy 

Chase Pavilion, 4300 Military Rd., 

Washington, DC 20015. 

Time: May 14, 2009, 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel at the Chevy 

Chase Pavilion, 4300 Military Rd., 

Washington, DC 20015. 

Time: May 15, 2009, 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel at the Chevy 

Chase Pavilion, 4300 Military Rd., 

Washington, DC 20015. 

Contact Person: Beata Buzas, PhD, 

Scientific Review Officer, National Institute 

on Alcohol Abuse and Alcoholism, National 

Institutes of Health, 5635 Fishers Lane, Rm. 

2081, Rockville, MD 20852. 301–443–0800. 

bbuzas@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS) 

Dated: April 10, 2009. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8901 Filed 4–20–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, May 6, 

2009, 9 a.m. to May 7, 2009, 10 p.m., 

National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on April 7, 2009, 74 FR 15739– 

15740. 

The meeting will be held May 28, 

2009 to May 29, 2009. The meeting time 

and location remain the same. The 

meeting is closed to the public. 

Dated: April 10, 2009. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8896 Filed 4–20–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Immunology. 

Date: May 6, 2009. 

Time: 10:30 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Patrick K. Lai, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2215, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1052, laip@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Immunology. 

Date: May 7, 2009. 

Time: 12 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Patrick K. Lai, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2215, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1052, laip@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel PROMISE II 

Support Centers. 

Date: May 18, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Michael Micklin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3136, 

MSC 7759, Bethesda, MD 20892, (301) 435– 

1258, micklinm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel. PROMISE II 

Research Centers. 

Date: May 19, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Michael Micklin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3136, 

MSC 7759, Bethesda, MD 20892, (301) 435– 

1258, micklinm@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences &; Technologies. Integrated Review 

Group, Biomaterials and Biointerfaces Study 

Section. 

Date: May 20–21, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Steven J. Zullo, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5146, 

MSC 7849, Bethesda, MD 20892, 301–435– 

2810, zullost@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group, 

Gastrointestinal Mucosal Pathobiology Study 

Section. 

Date: May 29, 2009. 

Time: 7:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Avenue Hotel Chicago, 160 East 

Huron, Chicago, IL 60611. 

Contact Person: Peter J. Perrin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

0682, perrinp@csr.nih.gov. 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 74, No. 75 / Tuesday, April 21, 2009 / Notices 18243 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Molecular 

Neuropharmacology and Signaling Study 

Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Deborah L. Lewis, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1224, lewisdeb@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes, Integrated Review 

Group, Language and Communication Study 

Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Weijia Ni, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3184, MSC 7848, Bethesda, MD 

20892, (301) 435–1507, niw@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group, Radiation Therapeutics and Biology 

Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Bo Hong, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 6194, MSC 7804, Bethesda, MD 

20892, 301–435–5879, hongb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cardiac 

Hypertrophy. 

Date: June 1, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Maqsood A. Wani, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2114, 

MSC 7814, Bethesda, MD 20892, 301–435– 

2270, wanimaqs@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience, Integrated Review 

Group, Anterior Eye Disease Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Jerry L. Taylor, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1175, tayIorje@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior, Integrated Review Group, 

Psychosocial Risk and Disease Prevention 

Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Tysons Corner Hotel, 

1960 Chain Bridge Road, McLean, VA 22102. 

Contact Person: Martha Faraday, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808, Bethesda, MD 20892, 301–435– 

3575, faradaym@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group, 

Behavioral Medicine, Interventions and 

Outcomes Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Rouge, 1315 16th Street, NW., 

Washington, DC 20036. 

Contact Person: Lee S. Mann, JD, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7848, Bethesda, MD 20892, 301–435– 

0677, mannl@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience, Integrated Review 

Group, Neural Basis of Psychopathology, 

Addictions and Sleep Disorders Study 

Section. 

Date: June 1–2, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Washington, DC, 

1250 22nd Street, NW., Washington, DC 

20037. 

Contact Person: Julius Cinque, MS, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1252, cinquej@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology, Integrated Review Group, 

Virology—B Study Section. 

Date: June 1–2, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Robert Freund, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3200, 

MSC 7848, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 10, 2009. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–8895 Filed 4–20–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control, Initial Review Group, 

(NCIPC, IRG) 

Correction: This notice was published 

in the Federal Register on April 13, 

2009, Volume 74, Number 69, Page 

16878. The times and participant pass 

code has been changed to the following: 

Times and Dates: 8 a.m.–8:15 a.m., April 

22, 2009 (Open); 8:15 a.m.–4 p.m., April 22, 

2009 (Closed). 

Place: Teleconference, toll free: (877) 468– 

4185, Participant. Passcode: 4475689. 

Contact Person For More Information: Jane 

Suen, Dr.P.H., M.S., NCIPC, CDC, 4770 

Buford Highway, NE., Mailstop F–62, 

Atlanta, Georgia 30341, Telephone: (770) 

488–4281. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 15, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–9188 Filed 4–20–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

mstockstill on PROD1PC66 with NOTICES